GH Secretagogues

Tesamorelin

SKU NA-070CAS 218949-48-5MW 5135.9
99.68% HPLCThird-party testedRUO · Research use only

Price range: $65.98 through $87.98

White lyophilized powder. CAS 218949-48-5, MW 5135.9. Reconstitute with bacteriostatic water. Purity 99.68% by RP-HPLC. Research use only — not for human or veterinary use.

Multi-vial pricing
HPLC verifiedPurity confirmed per lot
COA includedLot-specific certificate
Cold-chainShipped 2-8°C with packs
Lot traceableDocumented to dispatch
RUOThis product is sold for laboratory research use only. It is not a drug or supplement and is not for human or veterinary consumption, diagnostic or therapeutic use.
Description

Tesamorelin is a stabilized GHRH analog supplied by Nano Aminos strictly as a reference material for in-vitro and laboratory research. It is catalogued under CAS 218949-48-5, molecular formula C221H366N72O67S, and a molecular weight of 5135.9 g/mol.

Provided as a lyophilized powder (white solid), Tesamorelin is part of the Nano Aminos GH Secretagogues research range and is prepared for research use by reconstitution in bacteriostatic water using standard aseptic technique.

Every production lot is characterized by reversed-phase HPLC and mass spectrometry at 99.68% typical HPLC purity and ships with a lot-specific Certificate of Analysis (COA), so identity and purity can be independently confirmed before use. Vials are kept cold and protected from repeated freeze–thaw cycles. Tesamorelin is available in 5 mg and 10 mg research sizes.

Related research: browse the full GH Secretagogues category or compare IGF-1 LR3 and Sermorelin.

For research use only. Not for human or veterinary use. Tesamorelin is not a drug, food, or dietary supplement.

Specifications
CompoundTesamorelin
ClassificationStabilized GHRH analog
CAS number218949-48-5
Molecular formulaC221H366N72O67S
Molecular weight5135.9 g/mol
Purity99.68% by RP-HPLC (area %)
Physical formLyophilized powder
AppearanceWhite lyophilized powder
ReconstitutionBacteriostatic water
Lab documentation

Each production lot is released against an analytical specification and ships with the corresponding Certificate of Analysis.

Certificate of analysis

Tesamorelin 10 mg

Lot 526558341
Purity (HPLC-UV)
99.68%
Identity (LC-MS)
Confirmed
Net content
10.54 mg
Appearance
White lyophilized powder
Method
HPLC-UV with LC-MS confirmation
Reported
21 Jul 2026
Accession
2607170373
Download image

Opens on this page. Analysis by an independent laboratory. Research use only - not for human or veterinary use.

Storage & handling

Storage. Store lyophilized material at -20°C protected from light and moisture for long-term stability. After reconstitution, keep at 2-8°C and use within the documented in-use window.

Handling. Allow sealed vials to equilibrate to room temperature before opening to limit condensation. Reconstitute with the listed diluent using standard aseptic laboratory technique. Avoid repeated freeze-thaw cycles.

Safety. Handle as a laboratory research chemical. Wear appropriate PPE and follow your institution's chemical-handling and waste-disposal procedures.

Shipping

Dispatch. In-stock orders are processed on business days and shipped with temperature-controlled packaging and gel packs to preserve material integrity in transit.

Tracking. A tracking reference is issued at dispatch. Lab accounts can consolidate shipments and arrange standing orders.

Eligibility. Orders are accepted from researchers, resellers and institutions for laboratory research use only.

Selected research

Literature referencing this compound.

Publications relevant to this molecule, provided for research reference. Inclusion does not imply an approved use or any claim about the products sold here.

Phase 3 RCT
N Engl J Med. 2007;357(23):2359–2370
Metabolic effects of a growth hormone-releasing factor (tesamorelin) in patients with HIV
Falutz J, Allas S, Blot K, et al.
Phase 3 RCT
J Acquir Immune Defic Syndr. 2010;53(3):311–322
Effects of tesamorelin in HIV-infected patients with abdominal fat accumulation: an RCT with safety extension
Falutz J, Potvin D, Mamputu JC, et al.
Reference

Background reading on peptide chemistry and handling.